influenza
virus
major
threat
human
health
therefor
focu
nation
intern
health
author
among
influenza
viru
type
b
main
consid
caus
annual
epidem
high
morbid
consider
mortal
contrast
influenza
c
viru
regard
pathogen
minor
relev
caus
mild
clinic
unappar
diseas
nevertheless
recent
year
detect
influenza
c
hospitalis
young
children
sever
lower
respiratori
tract
diseas
report
thu
clinic
epidemiolog
signific
viru
speci
might
underestim
need
reassess
europ
burden
influenza
c
viru
infect
children
adult
larg
unknown
systemat
surveil
data
avail
studi
publish
mainli
focu
clinic
data
mostli
hospitalis
children
germani
surveil
data
sequenc
inform
circul
influenza
c
virus
ever
report
therefor
decid
search
influenza
c
outpati
sampl
collect
assembl
purpos
influenza
viru
surveil
germani
young
children
describ
highest
infect
rate
confin
studi
yearold
age
group
furthermor
sequenc
haemagglutinin
esteras
gene
influenza
cposit
sampl
phylogenet
characteris
detect
virus
sampl
collect
practition
particip
nation
influenza
surveil
distribut
complet
german
territori
repres
statist
valid
proport
german
popul
practition
continu
collect
nasal
throat
swab
nonhospitalis
patient
present
symptom
influenzalik
ill
ili
accord
european
union
eu
definit
acut
respiratori
infect
ari
ili
case
defin
sudden
diseas
onset
least
one
four
system
symptom
fever
feverish
malais
headach
myalgia
least
one
three
respiratori
symptom
cough
sore
throat
short
breath
ari
acut
respiratori
diseas
least
one
four
follow
symptom
fever
cough
rhinorrhoea
sore
throat
sampl
sent
german
nation
influenza
centr
accompani
complet
questionnair
patient
characterist
sampl
date
diseas
symptom
influenza
vaccin
statu
therapeut
intervent
ie
antivir
treatment
routin
analys
influenza
viru
type
b
human
respiratori
syncyti
viru
rsv
well
sinc
april
human
adenoviru
adv
metapneumoviru
hmpv
rhinoviru
hrv
sampl
store
afterward
studi
subset
sampl
select
total
number
sampl
taken
children
year
age
year
describ
supplementari
file
supplement
briefli
least
everi
second
sampl
chronolog
order
retrospect
analys
influenza
c
viru
extend
basi
coinfect
data
influenza
cposit
sampl
addit
test
human
parainfluenza
virus
type
coronavirus
posit
sampl
taken
april
furthermor
retrospect
examin
adv
hmpv
hrv
conduct
sentinel
surveil
cover
german
legisl
protect
infect
act
german
nation
surveil
influenza
respiratori
virus
furthermor
approv
ethic
committe
berlin
applic
number
addit
sampl
written
consent
given
inclus
research
studi
analys
done
pseudonymis
data
arriv
laboratori
cell
cultur
medium
minimum
essenti
medium
mem
sequenc
analys
cdna
synthesis
accuscript
hifi
revers
transcriptas
agil
santa
clara
us
primer
bind
conserv
end
rna
gene
segment
see
tabl
assay
valid
perform
synthet
doubl
strand
dna
string
gblock
idt
skoki
us
singleplex
well
duplex
format
includ
intern
control
fcv
well
plate
determin
linear
detect
rang
correl
r
quantif
cycl
c
q
valu
dilut
seri
copi
per
reaction
examin
duplic
pcr
effici
calcul
insert
slope
valu
standard
curv
formula
e
limit
detect
lod
establish
detect
probabl
calcul
probit
analys
result
examin
low
copi
number
genom
equival
per
reaction
appli
ibm
spss
statist
softwar
intraassay
precis
gblock
examin
sixfold
singl
run
interassay
precis
intraassay
data
extend
two
addit
run
doubl
reaction
reproduc
run
perform
consecut
day
independ
experi
precis
describ
standard
deviat
observ
c
q
valu
convent
pcr
sequenc
determin
gene
carri
total
reaction
volum
reaction
contain
extaq
buffer
dntp
thermo
fisher
scientif
waltham
us
dutp
ge
healthcar
chicago
us
extaq
polymeras
takara
kusatsu
japan
primer
metabion
planegg
germani
list
tabl
predilut
cdna
altern
superscript
monthli
distribut
yearold
children
number
sampl
test
influenza
c
well
test
coverag
among
sampl
receiv
tabl
use
amplicon
sequenc
case
nest
pcr
primer
yield
sequenc
span
complet
amplicon
sequenc
process
assembl
geneiou
softwar
deposit
global
initi
share
influenza
data
gisaid
www
gisaidorg
databas
appli
aminoacid
number
includ
signal
peptid
sequenc
analys
perform
geneiou
version
multipl
sequenc
align
compil
basi
mafft
algorithm
ntermin
sequenc
includ
signal
peptid
sequenc
mffslllmlgltea
well
ctermin
region
incomplet
sequenc
inform
last
nt
includ
stop
codon
exclud
align
phylogenet
analys
thu
cover
nt
complet
code
sequenc
calcul
includ
refer
sequenc
download
gisaid
databas
see
supplement
maximum
likelihood
tree
construct
appli
model
spr
tree
topolog
search
branch
reliabl
estim
perform
bootstrap
replic
tree
manual
edit
corel
draw
qpcr
assay
detect
influenza
c
virus
establish
singleplex
well
duplex
qpcr
includ
routin
intern
control
fcv
assay
prove
robust
sensit
tool
furthermor
show
crossreact
varieti
viral
respiratori
pathogen
human
genom
dna
valid
result
summaris
tabl
duplex
qpcr
approach
appli
retrospect
examin
throat
nasal
swab
sampl
gave
valid
qpcr
result
ie
yield
either
influenza
c
fcv
signal
duplex
qpcr
run
twenti
sampl
found
posit
influenza
c
viru
rna
c
q
valu
rang
posit
sampl
predominantli
taken
octob
april
reach
averag
posit
rate
month
per
month
figur
outsid
particular
winter
season
virus
identifi
sporad
detect
rate
januaryapril
octob
april
viru
detect
achiev
may
septemb
year
studi
also
particular
age
distribut
could
observ
figur
influenza
cposit
sampl
addit
examin
qpcr
identifi
respiratori
virus
half
influenza
cposit
patient
prove
coinfect
divers
respiratori
pathogen
tabl
influenza
c
c
q
valu
cover
complet
rang
patient
influenza
c
viru
infect
report
fever
cough
fifteen
patient
report
maximum
temperatur
remain
five
patient
maximum
temperatur
provid
addit
sudden
diseas
onset
rhiniti
sore
throat
muscular
pain
andor
headach
predomin
symptom
clinic
sign
pneumonia
report
one
patient
influenza
c
c
q
valu
also
low
amount
influenza
detect
sampl
patient
sole
influenza
c
viru
infect
sudden
diseas
onset
maximum
fever
patient
rhiniti
sore
throat
muscular
pain
andor
headach
report
similar
proport
sequenc
gene
achiev
sampl
three
yield
partial
sequenc
two
incomplet
sequenc
cover
consecut
stretch
nt
respect
three
incomplet
sequenc
characteris
base
nt
homolog
sequenc
two
fragment
sampl
ident
sampl
sequenc
belong
subgroup
csao
paulo
clade
similarli
sampl
sequenc
ident
sequenc
csao
paulo
sampl
group
subgroup
subclad
sampl
sequenc
similar
sao
paulo
lineag
cluster
similar
prototyp
strain
sequenc
five
lineag
lower
although
influenza
c
viru
discov
year
ago
littl
knowledg
biolog
epidemiolog
viru
type
studi
indic
low
clinic
impact
mild
symptom
spite
high
seropreval
popul
viru
detect
rare
find
led
conclus
influenza
c
infect
common
clinic
inappar
mild
requir
visit
doctor
addit
low
detect
rate
may
part
due
fact
earlier
time
viru
diagnost
mainli
base
viru
cultur
difficult
influenza
c
necessit
condit
differ
influenza
b
viru
cultiv
consequ
influenza
c
viru
diagnost
restrict
specialis
laboratori
correspondingli
rare
introduct
molecular
method
influenza
c
increasingli
includ
studi
respiratori
pathogen
clinic
diagnost
therebi
low
detect
rate
gener
popul
confirm
higher
clinic
impact
paediatr
patient
indic
influenza
c
describ
also
caus
lower
respiratori
tract
diseas
prospect
studi
decemb
may
includ
japanes
children
communityacquir
pneumonia
bronchiol
bronchiti
influenza
c
infect
identifi
even
preval
approxim
influenza
hmpv
studi
mostli
children
describ
symptom
influenza
c
infect
indistinguish
influenza
b
infect
although
maximum
bodi
temperatur
may
lower
fever
shorter
compar
influenza
finnish
militari
recruit
influenza
c
viru
caus
common
coldlik
symptom
occasion
result
pneumonia
bronchiti
europ
littl
inform
influenza
c
circul
publish
adult
seropreval
ca
found
franc
finland
unit
kingdom
appli
pcr
sampl
age
group
viru
detect
rate
report
normandyfr
scotland
spain
higher
detect
rate
found
two
adult
studi
finland
outsid
europ
similar
seropreval
well
compar
detect
rate
describ
australia
canada
japan
nigeria
philippin
peru
us
view
lack
knowledg
influenza
c
viru
circul
germani
decid
gener
first
systemat
data
basi
nation
influenza
viru
surveil
chose
examin
age
group
year
young
children
shown
highest
infect
rate
analys
repres
subset
sampl
receiv
age
group
sampl
correspond
month
first
valid
previous
publish
qpcr
duplex
routin
intern
control
fcv
extens
valid
effort
accord
intern
standard
found
singleplex
well
duplex
format
perform
high
sensit
specif
precis
therefor
appli
sampl
compil
identifi
influenza
c
rna
sampl
valid
qpcr
result
vast
major
viru
detect
found
sampl
collect
octob
april
signal
pronounc
viru
circul
month
posit
rate
novemb
sampl
collect
german
feder
state
viru
circul
confin
region
widespread
mayb
even
nationwid
viru
preval
howev
markedli
lower
winter
season
observ
studi
viru
could
detect
summer
month
absenc
summer
circul
congruenc
report
japan
franc
finland
spain
contradict
report
catalonia
spain
major
posit
sampl
taken
august
septemb
observ
time
span
upsurg
influenza
c
viru
circul
spring
also
observ
philippin
occur
japan
viru
circul
even
number
year
report
includ
year
howev
biennial
pattern
viru
circul
increas
timeshift
profil
also
describ
respiratori
virus
germani
therefor
conceiv
remain
open
studi
due
short
studi
period
present
limit
total
proport
influenza
cposit
patient
small
within
expect
rang
need
emphasis
though
obtain
overal
posit
rate
larg
base
month
winter
season
substanti
viru
circul
studi
popul
limit
access
clinic
data
conclus
drawn
regard
clinic
relev
influenza
c
viru
vast
major
patient
carri
viru
fulfil
eu
ili
definit
although
due
studi
design
may
bia
ili
case
period
influenza
b
viru
circul
find
concord
studi
ili
describ
major
influenza
c
infect
patient
bronchiti
bronchiol
report
patient
one
child
infect
also
influenza
viru
present
symptom
pneumonia
howev
proport
pneumonia
influenza
cposit
sampl
differ
consider
complet
sampl
collect
age
group
span
year
data
shown
ambul
set
thu
see
indic
accumul
lower
respiratori
tract
diseas
influenza
c
infect
patient
influenzalik
clinic
present
common
interestingli
substanti
share
influenza
cposit
sampl
show
coinfect
pathogen
report
also
studi
case
caus
ili
symptom
clearli
attribut
influenza
c
yet
use
qpcr
assay
compar
perform
characterist
lod
effici
comparison
obtain
c
q
valu
semiquantit
interpret
differ
pathogen
within
one
sampl
studi
major
coinfect
sampl
exhibit
highest
viral
load
influenza
c
includ
pneumonia
case
ca
higher
influenza
time
point
sampl
site
examin
four
sampl
influenza
c
c
q
close
detect
limit
thu
influenza
c
presum
minor
relev
repetit
sampl
patient
continu
parallel
assess
patient
clinic
present
could
clarifi
role
singl
pathogen
diseas
cours
includ
routin
influenza
surveil
system
therefor
judg
tempor
dynam
viru
replic
clinic
impact
viru
detect
due
slow
evolut
thu
high
antigen
homolog
influenza
c
viru
decid
characteris
german
sequenc
basi
gene
sequenc
glycoprotein
varieti
function
viral
replic
cycl
greatli
determin
antigen
viru
base
antigen
phylogenet
characterist
protein
distinct
viru
lineag
describ
name
prototyp
strain
c
csao
influenza
c
lineag
cluster
compris
isol
multitud
contin
indic
global
circul
viru
lineag
howev
four
lineag
seemingli
disappear
ctaylor
caichi
c
mississippi
cyamagata
ckanagawa
csao
paulo
lineag
detect
within
last
decad
posit
sampl
total
partial
near
fulllength
sequenc
could
gener
almost
exclus
detect
csao
paulo
lineag
virus
two
ckanagawa
virus
identifi
c
sao
paulo
sequenc
add
lineag
subclad
describ
matsuzaki
et
al
repres
c
total
sequenc
complet
incomplet
group
subclad
sampl
march
april
three
addit
sequenc
complet
incomplet
group
c
subclad
sampl
novemb
march
thu
virus
subclad
cocircul
winter
season
contrast
two
ckanagawa
lineag
virus
sampl
march
april
thu
outsid
period
increas
infect
rate
form
distinct
cluster
within
ckanagawa
clade
close
relat
c
kanagawa
virus
almost
ident
show
nt
homolog
although
sampl
distanc
closest
neighbour
even
homolog
nt
level
support
describ
genet
stabil
viru
type
compar
influenza
b
virus
possibl
also
reflect
antigen
properti
summaris
studi
first
report
influenza
c
circul
context
nationwid
outpati
influenza
surveil
system
europ
found
influenza
c
proport
sampl
accord
previou
report
increas
widespread
viru
circul
observ
winter
spring
month
virus
predominantli
belong
subclad
c
sao
paulo
lineag
virus
infect
patient
show
symptom
ili
includ
upper
well
lower
respiratori
tract
infect
although
associ
observ
clinic
symptom
remain
uncertain
major
case
due
identifi
coinfect
knowledg
need
viru
epidemiolog
transmiss
pattern
role
sole
mix
infect
well
associ
diseas
burden
especi
young
children
patient
lower
respiratori
tract
diseas
